Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • arthritis

    Tag: arthritis

    You Searched For "arthritis"
    DOP junks Geltec plea against NPPA decision on retail price of Ibuprofen Soft Gelatin Capsules

    DOP junks Geltec plea against NPPA decision on retail price of Ibuprofen Soft Gelatin Capsules

    Farhat Nasim28 July 2019 11:30 AM IST
    New Delhi: Through a recent decision, the Department of Pharmaceuticals (DOP) has rejected the review application filed by Geltec Private Limited...
    Sun Pharma enters licensing agreement with CMS for arthritis drug Tildrakizumab

    Sun Pharma enters licensing agreement with CMS for arthritis drug Tildrakizumab

    Medical Dialogues Bureau28 Jun 2019 12:30 PM IST
    The initial tenure of the agreement between Sun Pharma and CMS shall be 15 years from the first commercial sale of Tildrakizumab in Greater China and...
    Cipla gets no USFDA observations for Indore facility

    Cipla gets no USFDA observations for Indore facility

    Farhat Nasim18 May 2019 9:45 AM IST
    The US health regulator conducted a post-approval inspection at Cipla Ltd's Indore facility from 13th May to 17th May 2019. New Delhi: Drug firm Cipla...
    Zydus Cadila gets final USFDA nod for Leflunomide tablets to treat arthritis

    Zydus Cadila gets final USFDA nod for Leflunomide tablets to treat arthritis

    Farhat Nasim26 April 2019 12:49 PM IST
    Leflunomide tablet is used to treat rheumatoid arthritis, a condition affecting multiple small and large joints of the body.New Delhi: Drug firm Zydus...
    Zydus Cadila gets tentative USFDA nod to Tofacitinib tablets for treating arthritis

    Zydus Cadila gets tentative USFDA nod to Tofacitinib tablets for treating arthritis

    Farhat Nasim6 April 2019 3:00 PM IST
    Tofacitinib is used alone or with other medications to treat moderate to severe forms of rheumatoid arthritis, the company said in a BSE filing. New...
    Novartis sees 2019 growth as it sheds eyecare unit, narrows focus

    Novartis sees 2019 growth as it sheds eyecare unit, narrows focus

    Garima30 Jan 2019 9:00 AM IST
    Novartis said sales of its Entresto heart failure medicine accelerated along with revenue from its psoriasis-and-arthritis blockbuster...
    Abbvie to record $4 billion impairment charges on Stemcentrx assets

    Abbvie to record $4 billion impairment charges on Stemcentrx assets

    Medical Dialogues Bureau6 Jan 2019 9:00 AM IST
    The drugmaker acquired Rova-T through its $5.8 billion acquisition of Stemcentrx in 2016, as it aimed to enter the broad and lucrative arena of solid...
    AbbVie says deaths in arthritis trial not linked to drug

    AbbVie says deaths in arthritis trial not linked to drug

    Ruby Khatun Khatun13 Sept 2017 1:42 PM IST
    AbbVie Inc said on Monday two patients died in a late-stage trial of its rheumatoid arthritis drug but that the deaths were not linked to the drug,...

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok